Advice
in the absence of a submission from the holder of the marketing authorisation:
dexamethasone (Neofordex®) is not recommended for use within NHS Scotland.
Indication under review: In adults for the treatment of symptomatic multiple myeloma in combination with other medicinal products
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice135KB (PDF)
Medicine details
- Medicine name:
- dexamethasone 40mg tablets (Neofordex)
- SMC ID:
- 1322/18
- Indication:
- In adults for the treatment of symptomatic multiple myeloma in combination with other medicinal products
- Pharmaceutical company
- Aspire Pharma Ltd
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 12 March 2018